Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 Am J Med
13 Ann Intern Med
1 Antiviral Res
4 Biochem Biophys Res Commun
10 BMJ
7 Cell
4 Epidemiol Infect
7 J Clin Microbiol
1 J Exp Med
2 J Gen Virol
33 J Infect
7 J Infect Dis
1 J Virol Methods
17 Lancet
9 N Engl J Med
1 PLoS Med
13 PLoS One
4 Proc Natl Acad Sci U S A
24 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

    Aspirin Use for Primary Cardiovascular Prevention During the COVID-19 Pandemic.
    Am J Med. 2021;134:e299.

  2. CHIANG KC, Gupta A
    Aspirin Resistance in Obese and Elderly Patients with COVID-19?
    Am J Med. 2021;134:e297.

    Ann Intern Med

  3. CLIFT AK, Coupland CAC, Keogh RH, Hemingway H, et al
    COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/M20-4986.

  4. CHOPRA V, Flanders SA, O'Malley M, Malani AN, et al
    Sixty-Day Outcomes Among Patients Hospitalized With COVID-19.
    Ann Intern Med. 2020 Nov 11. doi: 10.7326/M20-5661.

  5. COOK DJ, Takaoka A, Hoad N, Swinton M, et al
    Clinician Perspectives on Caring for Dying Patients During the Pandemic : A Mixed-Methods Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-6943.
    PubMed         Abstract available

  6. FU Y, Li Y, Guo E, He L, et al
    Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-3337.
    PubMed         Abstract available

  7. SHIELS MS, Almeida JS, Garcia-Closas M, Albert PS, et al
    Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020.
    Ann Intern Med. 2020 Dec 15. doi: 10.7326/M20-7385.
    PubMed         Abstract available

  8. ALSAN M, Stanford FC, Banerjee A, Breza E, et al
    Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled Trial.
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-6141.
    PubMed         Abstract available

  9. LOSINA E, Leifer V, Millham L, Panella C, et al
    College Campuses and COVID-19 Mitigation: Clinical and Economic Value.
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-6558.
    PubMed         Abstract available

  10. CZYPIONKA T, Greenhalgh T, Bassler D, Bryant MB, et al
    Masks and Face Coverings for the Lay Public : A Narrative Update.
    Ann Intern Med. 2020 Dec 29. doi: 10.7326/M20-6625.
    PubMed         Abstract available

  11. TUITE AR, Zhu L, Fisman DN, Salomon JA, et al
    Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8137.

  12. BARNABAS RV, Wald A
    A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8060.

  13. PALTIEL AD, Zheng A, Schwartz JL
    Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-7866.

  14. BARNETT BS, Carlo AD, Mezzadri A, Ruwanpura KN, et al
    The Invisible People Behind Our Masks.
    Ann Intern Med. 2021;174:550-551.

  15. BASTOS ML, Perlman-Arrow S, Menzies D, Campbell JR, et al
    The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2021 Jan 12. doi: 10.7326/M20-6569.
    PubMed         Abstract available

    Antiviral Res

  16. MILANI M, Donalisio M, Bonotto RM, Schneider E, et al
    Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
    Antiviral Res. 2021 Mar 10:105055. doi: 10.1016/j.antiviral.2021.105055.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  17. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    PubMed         Abstract available

  18. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    PubMed         Abstract available

  19. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    PubMed         Abstract available

  20. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    PubMed         Abstract available


    Reporting of AstraZeneca studies may have caused vaccine reservations.
    BMJ. 2021;373:n937.

    UK deaths in 2020: how do they compare with previous years?
    BMJ. 2021;373:n896.

  23. DYER O
    Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
    BMJ. 2021;373:n969.

  24. TANG JW, Marr LC, Li Y, Dancer SJ, et al
    Covid-19 has redefined airborne transmission.
    BMJ. 2021;373:n913.

  25. GOPAL DP, Rao M
    Playing hide and seek with structural racism.
    BMJ. 2021;373:n988.

  26. DAY FJ
    Covid-19: public health leaders have been exceptional, but we need a whole new approach to society.
    BMJ. 2021;373:n959.

  27. WHITE C, Connolly B, Rowland MJ
    Rehabilitation after critical illness.
    BMJ. 2021;373:n910.

  28. SHIMIZU K, Sridhar D, Taniguchi K, Shibuya K, et al
    Reconsider this summer's Olympic and Paralympic games.
    BMJ. 2021;373:n962.

    Thrombosis after covid-19 vaccination.
    BMJ. 2021;373:n958.

  30. MODI N, Hanson M
    Health of women and children is central to covid-19 recovery.
    BMJ. 2021;373:n899.


  31. ZHANG X, Liu Y, Liu J, Bailey AL, et al
    A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
    Cell. 2021;184:2229-2238.
    PubMed         Abstract available

  32. YEUNG ML, Teng JLL, Jia L, Zhang C, et al
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Cell. 2021;184:2212-2228.
    PubMed         Abstract available

  33. SUPASA P, Zhou D, Dejnirattisai W, Liu C, et al
    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
    Cell. 2021;184:2201-2211.
    PubMed         Abstract available

  34. DEJNIRATTISAI W, Zhou D, Ginn HM, Duyvesteyn HME, et al
    The antigenic anatomy of SARS-CoV-2 receptor binding domain.
    Cell. 2021;184:2183-2200.
    PubMed         Abstract available

  35. MILLS RJ, Humphrey SJ, Fortuna PRJ, Lor M, et al
    BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Cell. 2021;184:2167-2182.
    PubMed         Abstract available

  36. SCHNEIDER JL, Rowe JH, Garcia-de-Alba C, Kim CF, et al
    The aging lung: Physiology, disease, and immunity.
    Cell. 2021;184:1990-2019.
    PubMed         Abstract available

  37. The origins of viral infection sleuth.
    Cell. 2021;184:1960-1961.
    PubMed         Abstract available

    Epidemiol Infect

  38. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    PubMed         Abstract available

  39. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    PubMed         Abstract available

  40. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    PubMed         Abstract available

  41. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    PubMed         Abstract available

    J Clin Microbiol

  42. BARAT B, Das S, De Giorgi V, Henderson DK, et al
    Pooled Saliva Specimens for SARS-CoV-2 Testing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  43. YUSUF E, Vonk A, van den Akker JPC, Bode L, et al
    Frequency of Positive Aspergillus Tests in COVID-19 Patients in Comparison to Other Patients with Pulmonary Infections Admitted to the ICU.
    J Clin Microbiol. 2020 Dec 4. pii: JCM.02278-20. doi: 10.1128/JCM.02278.
    PubMed         Abstract available

  44. FISCHER C, Mogling R, Melidou A, Kuhne A, et al
    Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  45. MOSTAFA HH, Carroll KC, Hicken R, Berry GJ, et al
    Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  46. THERRIEN C, Serhir B, Belanger-Collard M, Skrzypczak J, et al
    Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  47. PERCHETTI GA, Huang ML, Mills MG, Jerome KR, et al
    Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  48. KILIC A, Hiestand B, Palavecino E
    Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19.
    J Clin Microbiol. 2021;59.

    J Exp Med

  49. BASTARD P, Orlova E, Sozaeva L, Levy R, et al
    Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Gen Virol

  50. PEACOCK TP, Penrice-Randal R, Hiscox JA, Barclay WS, et al
    SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  51. SMITHER SJ, Eastaugh LS, Findlay JS, Laws TR, et al
    Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Infect

  52. T U, Am DR, Bm W, Ar H, et al
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
    J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.

  53. ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
    Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
    J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.

  54. ELFIKY AA, Ibrahim IM
    Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
    J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.

  55. GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
    Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
    J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.

  56. ALEMANY A, Baro B, Ouchi D, Rodo P, et al
    Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
    J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.

  57. NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
    Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.

  58. KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
    Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.

  59. AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
    Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
    J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.

  60. MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
    Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
    J Infect. 2021;82:186-230.

  61. CHEN PJ, Chao CM, Lai CC
    Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
    J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.

  62. BARRASA H, Martin A, Maynar J, Rello J, et al
    High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.

  63. FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
    Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.

  64. MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
    Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.

  65. GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
    SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
    PubMed         Abstract available

  66. VOICU S, Chousterman BG, Bonnin P, Deye N, et al
    Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.

  67. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.

  68. DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
    Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
    J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
    PubMed         Abstract available

  69. TUBIANA S, Burdet C, Houhou N, Thy M, et al
    High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.

  70. MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
    Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
    J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
    PubMed         Abstract available

  71. HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
    Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
    PubMed         Abstract available

  72. MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
    Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
    J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
    PubMed         Abstract available

  73. THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
    IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
    PubMed         Abstract available

  74. SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
    Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
    J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.

  75. TORRES I, Poujois S, Albert E, Alvarez G, et al
    Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
    J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.

  76. YANG H, Liang X, Hou H, Xu J, et al
    The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.

  77. NADAL M, Lassel L, Denis M, Gibelin A, et al
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.

  78. SCUTT DG, Overall DA
    Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.

  79. BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
    Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.

  80. ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
    Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.

  81. TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
    Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.

  82. MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
    Early clinical experience with imatinib in COVID-19: searching for a dual effect.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.

  83. DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
    Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.

  84. LI G, Niu J, Fan X, Chen T, et al
    The chilly climate may increase the chance of infecting COVID-19.
    J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.

    J Infect Dis

  85. THIEDE JM, Gress AR, Libby SD, Ronayne CE, et al
    Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial.
    J Infect Dis. 2021;223:1339-1344.
    PubMed         Abstract available

  86. BAUER W, Ulke J, Galtung N, Strasser-Marsik LC, et al
    Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department.
    J Infect Dis. 2021;223:1497-1499.

  87. JANSSEN NAF, Grondman I, de Nooijer AH, Boahen CK, et al
    Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    J Infect Dis. 2021;223:1322-1333.
    PubMed         Abstract available

  88. LUZZATTO-FEGIZ P, Temprano-Coleto F, Peaudecerf FJ, Landel JR, et al
    UVB Radiation Alone May Not Explain Sunlight Inactivation of SARS-CoV-2.
    J Infect Dis. 2021;223:1500-1502.

  89. DAVIS MF, Innes GK
    The Cat's in the Bag: Despite Limited Cat-to-Cat Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, One Health Surveillance Efforts Are Needed.
    J Infect Dis. 2021;223:1309-1312.

  90. BAO L, Song Z, Xue J, Gao H, et al
    Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
    J Infect Dis. 2021;223:1313-1321.
    PubMed         Abstract available

  91. BOLOTIN S, Tran V, Osman S, Brown KA, et al
    SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
    J Infect Dis. 2021;223:1334-1338.
    PubMed         Abstract available

    J Virol Methods

  92. DANILENKO DM, Eropkin MY, Leonenko VN, Konovalova NI, et al
    Assessment of rat polyclonal antisera's suitability in hemagglutination inhibition assay for influenza surveillance and antigenic mapping.
    J Virol Methods. 2021;293:114170.
    PubMed         Abstract available


    Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.
    JAMA. 2021 Mar 18. pii: 2777828. doi: 10.1001/jama.2021.4295.

    Outcomes for Patients Following Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777784. doi: 10.1001/jama.2021.3430.


  95. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.

  96. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.

  97. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.

  98. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.

  99. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.

    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.

  101. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.

  102. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.

  103. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    PubMed         Abstract available

  104. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.

  105. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.

  106. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.

  107. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.

  108. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.

  109. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.

    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.

  111. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.

    N Engl J Med

  112. RUBIN EJ, Longo DL, Baden LR
    Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMe2103108.

  113. GORDON AC, Mouncey PR, Al-Beidh F, Rowan KM, et al
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2100433.
    PubMed         Abstract available

  114. ROSAS IO, Brau N, Waters M, Go RC, et al
    Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2028700.
    PubMed         Abstract available

  115. STEELFISHER GK, Blendon RJ, Caporello H
    An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.

    Preparing for the Future - Nanobodies for Covid-19?
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMcibr2101205.

  117. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    N Engl J Med. 2021;384:e70.

  118. MECKLAI K, Smith N, Stern AD, Kramer DB, et al
    Remote Patient Monitoring - Overdue or Overused?
    N Engl J Med. 2021;384:1384-1386.

  119. DODD LE, Freidlin B, Korn EL
    Platform Trials - Beware the Noncomparable Control Group.
    N Engl J Med. 2021;384:1572-1573.

  120. RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    N Engl J Med. 2021;384:e73.

    PLoS Med

  121. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    PubMed         Abstract available

    PLoS One

  122. UMUHOZA T, Bulimo WD, Oyugi J, Musabyimana JP, et al
    Prevalence of human respiratory syncytial virus, parainfluenza and adenoviruses in East Africa Community partner states of Kenya, Tanzania, and Uganda: A systematic review and meta-analysis (2007-2020).
    PLoS One. 2021;16:e0249992.
    PubMed         Abstract available

  123. DANILENKO AV, Kolosova NP, Shvalov AN, Ilyicheva TN, et al
    Evaluation of HA-D222G/N polymorphism using targeted NGS analysis in A(H1N1)pdm09 influenza virus in Russia in 2018-2019.
    PLoS One. 2021;16:e0251019.
    PubMed         Abstract available

  124. PARMLEY LE, Hartsough K, Eleeza O, Bertin A, et al
    COVID-19 preparedness at health facilities and community service points serving people living with HIV in Sierra Leone.
    PLoS One. 2021;16:e0250236.
    PubMed         Abstract available

  125. ZOOROB D, Shah S, La Saevig D, Murphy C, et al
    Insight into resident burnout, mental wellness, and coping mechanisms early in the COVID-19 pandemic.
    PLoS One. 2021;16:e0250104.
    PubMed         Abstract available

  126. PHADNIS R, Wickramasinghe C, Zevallos JC, Davlin S, et al
    Leveraging mobile phone surveys during the COVID-19 pandemic in Ecuador and Sri Lanka: Methods, timeline and findings.
    PLoS One. 2021;16:e0250171.
    PubMed         Abstract available

  127. CHATTERJEE A, Wu G, Primakov S, Oberije C, et al
    Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.
    PLoS One. 2021;16:e0249920.
    PubMed         Abstract available

  128. ASGARI S, Trajkovic J, Rahmani M, Zhang W, et al
    An observational study of engineering online education during the COVID-19 pandemic.
    PLoS One. 2021;16:e0250041.
    PubMed         Abstract available

  129. YANG XF, Li MQ, Liao LL, Feng H, et al
    A qualitative study of the first batch of medical assistance team's first-hand experience in supporting the nursing homes in Wuhan against COVID-19.
    PLoS One. 2021;16:e0249656.
    PubMed         Abstract available

  130. MCGOVERN OL, Stenger M, Oliver SE, Anderson TC, et al
    Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.
    PLoS One. 2021;16:e0249901.
    PubMed         Abstract available

  131. KLISE K, Beyeler W, Finley P, Makvandi M, et al
    Analysis of mobility data to build contact networks for COVID-19.
    PLoS One. 2021;16:e0249726.
    PubMed         Abstract available

  132. BATES BR, Tami A, Carvajal A, Grijalva MJ, et al
    Knowledge, attitudes, and practices towards COVID-19 among Venezuelans during the 2020 epidemic: An online cross-sectional survey.
    PLoS One. 2021;16:e0249022.
    PubMed         Abstract available

  133. GUEDJ K, Uzzan M, Soudan D, Trichet C, et al
    I-FABP is decreased in COVID-19 patients, independently of the prognosis.
    PLoS One. 2021;16:e0249799.
    PubMed         Abstract available

  134. ANAND S, Montez-Rath ME, Han J, Garcia P, et al
    Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
    PLoS One. 2021;16:e0249466.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  135. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  136. BAZANT MZ, Bush JWM
    A guideline to limit indoor airborne transmission of COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  137. MALONE B, Chen J, Wang Q, Llewellyn E, et al
    Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  138. SAWATZKI K, Hill NJ, Puryear WB, Foss AD, et al
    Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  139. DADARI I, Higgins-Steele A, Sharkey A, Charlet D, et al
    Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
    Vaccine. 2021;39:2434-2444.
    PubMed         Abstract available

  140. GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
    PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
    PubMed         Abstract available

  141. ZHANG Y, Li D, Zhao H, Wang L, et al
    The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.

  142. RUSSO AG, Decarli A, Valsecchi MG
    Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
    PubMed         Abstract available

  143. KUTER BJ, Offit PA, Poland GA
    The development of COVID-19 vaccines in the United States: Why and how so fast?
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.

  144. KOCHHAR S, Dube E, Graham J, Jee Y, et al
    COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.

  145. PAGLIUSI S, Hayman B, Jarrett S
    Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
    PubMed         Abstract available

  146. BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
    Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
    PubMed         Abstract available

  147. OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
    Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
    PubMed         Abstract available

  148. KWON JH, Criado MF, Killmaster L, Ali MZ, et al
    Efficacy of two vaccines against recent emergent antigenic variants of clade highly pathogenic avian influenza viruses in Bangladesh.
    Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
    PubMed         Abstract available

  149. VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
    Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
    PubMed         Abstract available

  150. ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
    Are vaccines against COVID-19 tailored to the most vulnerable people?
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.

  151. SCHNEIKART G, Tavarini S, Sammicheli C, Torricelli G, et al
    The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31371.
    PubMed         Abstract available

  152. WENTZELL E, Racila AM
    The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
    PubMed         Abstract available

  153. GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
    U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
    PubMed         Abstract available

  154. ANGELIS A, Darrow J
    Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.

  155. ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
    Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
    PubMed         Abstract available

  156. GOLD MS, Lincoln G, Cashman P, Braunack-Mayer A, et al
    Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
    Vaccine. 2021;39:332-342.
    PubMed         Abstract available

  157. HAEDER SF
    Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
    PubMed         Abstract available

  158. MARELLAPUDI A, King AR, Bednarczyk RA
    Presentation of caregiver-specific vaccine-related information on National Cancer Institute designated cancer center websites.
    Vaccine. 2020 Aug 1. pii: S0264-410X(20)30983.
    PubMed         Abstract available

  159. VERDIJK P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, et al
    First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
    Vaccine. 2020 Jul 25. pii: S0264-410X(20)30947.
    PubMed         Abstract available

  160. BALZARINI F, Frascella B, Oradini-Alacreu A, Gaetti G, et al
    Does the use of personal electronic health records increase vaccine uptake? A systematic review.
    Vaccine. 2020 Jun 30. pii: S0264-410X(20)30738.
    PubMed         Abstract available

  161. GUIDRY JPD, Coman IA, Vraga EK, O'Donnell NH, et al
    (S)pin the flu vaccine: Recipes for concern.
    Vaccine. 2020 Jun 24. pii: S0264-410X(20)30773.
    PubMed         Abstract available

  162. BARAL R, Li X, Willem L, Antillon M, et al
    The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30822.
    PubMed         Abstract available

    Virus Res

  163. GHOSH N, Saha I, Sharma N, Nandi S, et al
    Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
    Virus Res. 2021;298:198401.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.